ASSET PURCHASE AGREEMENT among BRICKELL BIOTECH, INC., BRICKELL SUBSIDIARY, INC., BOTANIX SB INC. and solely for purposes of Article I, Section 5.10, Article VI and Article VII BOTANIX PHARMACEUTICALS LIMITED Dated as of May 3, 2022Asset Purchase Agreement • May 3rd, 2022 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • Delaware
THIS ASSET PURCHASE AGREEMENT, dated as of May 3, 2022 (the “Closing Date”), is made and entered into among Brickell Biotech, Inc., a Delaware corporation (“Brickell”), Brickell Subsidiary, Inc. (d/b/a Brickell Biotech, Inc.), a Delaware corporation (“Brickell Sub” and, together with Brickell, the “Sellers” and each a “Seller”), Botanix SB Inc., a Delaware corporation (“Buyer”), and solely for purposes of Article I, Section 5.10, Article VI and Article VII, Botanix Pharmaceuticals Limited, an Australian company (“Guarantor”).
TRANSITION SERVICES AGREEMENTTransition Services Agreement • May 3rd, 2022 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances)
This TRANSITION SERVICES AGREEMENT (this “Agreement”) is entered into effective as of the 3rd day of May 2022 (the “Effective Date”) by and between Botanix SB Inc., a Delaware corporation with principal place of business at 3602 Buyer Drive, Suite 160, King of Prussia, PA 19406 (“Botanix”), and Brickell Biotech, Inc., a Delaware corporation with principal place of business at 5777 Central Avenue, Ste 102, Boulder, Colorado USA 80301 (“BBI”), with each individually as a “Party” and collectively as the “Parties”.
RIGHTS AGREEMENTRights Agreement • May 3rd, 2022 • Brickell Biotech, Inc. • Biological products, (no disgnostic substances) • Florida
This Rights Agreement (“Rights Agreement”), effective as of May 3, 2022 (the “Effective Date”), is made by and among (a) Bodor Laboratories, Inc. (“BLI”), a Florida corporation having its principal place of business located at 4400 Biscayne Blvd., Miami, Florida 33137, (b) Brickell Subsidiary, Inc., d/b/a Brickell Biotech, Inc. (“Brickell Sub”), a Delaware corporation having its principal place of business located at 5777 Central Avenue, Boulder, Colorado 80301, and (c) Brickell Biotech, Inc., the parent of Brickell Sub (“Brickell Parent” and, together with Brickell Sub, collectively as “Brickell”). BLI and Brickell also shall be known individually as a “Party” or together as the “Parties”, according to the context.
